ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CRISPR breakthrough ignites hope of using pigs as organ donors – ScienceNordic

Continue reading

2017-09-12 Michael Zand NEWS

MediSix Therapeutics Signs Exclusive Licensing Agreement with the National University of Singapore – Markets Insider

MediSix Therapeutics Signs Exclusive Licensing Agreement with the National University of SingaporeMarkets InsiderLightstone Singapore, L.P. and Professor Dario Campana from the Department of Pediatrics, NUS Yong Loo Lin School of Medicine founded Medi… Continue reading

2017-09-12 Michael Zand NEWS

Modulating T-cell metabolism uncovers new technology for enhancing immunotherapy – Medical Xpress

Modulating T-cell metabolism uncovers new technology for enhancing immunotherapyMedical XpressT lymphocytes found in tumors and implicated in killing tumor cells cope with the shortage of oxygen and nutrients in the tumor microenvironment by using fat … Continue reading

2017-09-12 Michael Zand NEWS

UCLA Launches First-of-Its-Kind Stem Cell Trial to Combat Cancer – Los Angeles Business Journal

Los Angeles Business JournalUCLA Launches First-of-Its-Kind Stem Cell Trial to Combat CancerLos Angeles Business JournalScientists at UCLA have launched the first genetically engineered blood stem cell clinical trial to fight cancer thanks to $20 milli… Continue reading

2017-09-12 Michael Zand NEWS

Antibody-created stem cells may have superior properties – The San Diego Union-Tribune

The San Diego Union-TribuneAntibody-created stem cells may have superior propertiesThe San Diego Union-TribuneHuman induced pluripotent stem (iPS) cell colonies created from adult skin cells. Blue represents all DNA. Green and red indicates cell surfac… Continue reading

2017-09-12 Michael Zand NEWS

New Gene-Therapy Treatments Will Carry Whopping Price Tags – New York Times

CRISPR breakthrough ignites hope of using pigs as organ donors
ScienceNordic
It is the second problem that scientists have now solved with the gene-editing tool, CRISPR. “We’ve switched off the porcine endogenous retroviruses (PERVs) in the pigs, so that the PERVs can no longer replicate itself and infect people,” says Luo.

Continue reading

2017-09-11 Michael Zand NEWS

Nivolumab/Ipilimumab Improves Survival Versus Sunitinib in mRCC – OncLive


New York Times

New Gene–Therapy Treatments Will Carry Whopping Price Tags
New York Times
The first gene therapy treatment in the United States was approved recently by the Food and Drug Administration, heralding a new era in medicine that is coming faster than most realize — and that perhaps few can afford. The treatment, Kymriah, made by …
A new cancer drug may be the first in a line of revolutionary treatmentsChicago Tribune

all 3 news articles »

Continue reading

2017-09-11 Michael Zand NEWS

First CRISPR Technology Presented at Supply Side West Following Success in Singapore – Natural Products INSIDER

First CRISPR Technology Presented at Supply Side West Following Success in SingaporeNatural Products INSIDERLODAAT Pharma will be presenting a First-of-Its-Kind, cutting-edge session on CRISPR technology at Supply Side West, LODAAT Booth#WW143. The ses… Continue reading

2017-09-11 Michael Zand NEWS
  • 1
  • …
  • 1,217
  • 1,218
  • 1,219
  • 1,220
  • 1,221
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

OncLive

Nivolumab/Ipilimumab Improves Survival Versus Sunitinib in mRCC
OncLive
In those with PD-L1 expression ≥1%, the Median PFS was significantly longer with the immunotherapy combination than with sunitinib (22.9 vs 5.9 months; HR, 0.48; P = .0003). Those with PD-L1 expression <1% did not benefit from the combination (HR, …
Nivolumab cuts relapse by one third compared to IpilimumabEuropean Pharmaceutical Review
Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanomaMedical Xpress

all 11 news articles »